Courts have reasoned that challenging substantiation is best left for state agencies and the Federal Trade Commission, so private individuals must actually allege the existence of extrinsic evidence, such as conflicting studies, that would show that the challenged statement is false or misleading
Among the 12% of adults who have ever taken GLP-1 drugs, most report taking them, at least in part, to treat a chronic condition like diabetes or heart disease, with fewer saying they took them only to lose weight
It should state the clinical justification for using a compounded drug, such as the unavailability of the FDA-approved product due to a shortage
Feb 2022;61(1):413-428
Many patients can continue GLP-1 receptor agonists
Signs Your Semaglutide May Have Been Stored Improperly Compromised semaglutide often shows visible signs before you inject it